BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,316,242 | -52.7% | 197,634 | +32.5% | 0.01% | -63.2% |
| Q1 2023 | $2,782,430 | +43.2% | 149,112 | +60.5% | 0.02% | +58.3% |
| Q1 2022 | $1,943,000 | -3.1% | 92,928 | -5.8% | 0.01% | +9.1% |
| Q4 2021 | $2,005,000 | +10.5% | 98,638 | +64.9% | 0.01% | -8.3% |
| Q3 2021 | $1,815,000 | -9.3% | 59,803 | -13.2% | 0.01% | -7.7% |
| Q2 2021 | $2,002,000 | -34.6% | 68,900 | -2.9% | 0.01% | -38.1% |
| Q1 2021 | $3,061,000 | +206.4% | 70,924 | +228.0% | 0.02% | +110.0% |
| Q4 2020 | $999,000 | -47.8% | 21,624 | -51.0% | 0.01% | -56.5% |
| Q3 2020 | $1,914,000 | +158.6% | 44,152 | +216.3% | 0.02% | +130.0% |
| Q2 2020 | $740,000 | – | 13,960 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 550,000 | $23,848,000 | 3.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 269,300 | $11,677,000 | 1.15% |
| Avidity Partners Management LP | 538,000 | $23,328,000 | 1.08% |
| Knoll Capital Management, LLC | 20,000 | $867,000 | 0.71% |
| Maven Securities LTD | 200,000 | $8,610,000 | 0.71% |
| Prosight Management, LP | 29,800 | $1,292,000 | 0.62% |
| Artemis Investment Management LLP | 1,001,708 | $43,383,000 | 0.54% |
| Ikarian Capital, LLC | 150,000 | $6,504,000 | 0.47% |
| AlphaCentric Advisors LLC | 20,000 | $867,000 | 0.42% |
| MOODY ALDRICH PARTNERS LLC | 19,872 | $862,000 | 0.18% |